Neonatal hyperbilirubinemia and the role of unbound bilirubin

References

• Sticova E, Jirsa M. New insights in bilirubin metabolism and their clinical implications. World J Gastroenterol. 2013;19(38):6398–6407.
   PubMed Web of Science ®Google Scholar
• Stocker R, Yamamoto Y, McDonagh AF, et al. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235(4792):1043–1046.
   PubMed Web of Science ®Google Scholar
• Dore S, Takahashi M, Ferris CD, et al. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci U S A. 1999;96(5):2445–2450.
   PubMed Web of Science ®Google Scholar
• Gitto E, Reiter RJ, Karbownik M, et al. Causes of oxidative stress in the pre- and perinatal period. Biol Neonate. 2002;81(3):146–157.
   PubMedGoogle Scholar
• Hegyi T, Goldie E, Hiatt M. The protective role of bilirubin in oxygen-radical diseases of the preterm infant. J Perinatol. 1994;14(4):296–300.
   PubMedGoogle Scholar
• Zhu J, Xu Y, Zhang G, et al. Total serum bilirubin levels during the first 2 days of life and subsequent neonatal morbidity in very low birth weight infants: a retrospective review. Eur J Pediatr. 2012;171(4):669–674.
   PubMed Web of Science ®Google Scholar
• Benaron DA, Bowen FW. Variation of initial serum bilirubin rise in newborn infants with type of illness. Lancet. 1991;338(8759):78–81.
   PubMed Web of Science ®Google Scholar
• Kujabi ML, Petersen JP, Pedersen MV, et al. Neonatal jaundice and autism spectrum disorder: a systematic review and meta-analysis. Pediatr Res. 2021;90(5):934–949.
   PubMed Web of Science ®Google Scholar
• Brown AK, Johnson LH. Loss of concern about jaundice and the reemergence of kernicterus in full term infants in the ear of managed care. In: Fanaroff AA, Klaus MH, editors. Yearbook of neonatal and perinatal medicine. St. Louis (MO): Mosby-Year Book, Inc; 1996.
   Google Scholar
• Bhutani VK, Zipursky A, Blencowe H, et al. Neonatal hyperbilirubinemia and rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res. 2013;74(Suppl. 1):86–100.
   PubMedGoogle Scholar
• Lee AC, Folger LV, Rahman M, et al. A novel icterometer for hyperbilirubinemia screening in low-resource settings. Pediatrics. 2019;143(5):e20182039.
   PubMed Web of Science ®Google Scholar
• Schreiner RL, Glick MR. Interlaboratory bilirubin variability. Pediatrics. 1982;69(3):277–281.
   PubMed Web of Science ®Google Scholar
• Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. 1999;103(1):6–14.
   PubMed Web of Science ®Google Scholar
• Eggert LD, Wiedmeier SE, Wilson J, et al. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. Pediatrics. 2006;117(5):e855–e862.
   PubMed Web of Science ®Google Scholar
• Drummond GS, Kappas A. Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation. Proc Natl Acad Sci U S A. 1981;78(10):6466–6470.
   PubMed Web of Science ®Google Scholar
• Lucey J, Ferriero M, Hewitt J. Prevention of hyperbilirubinemia of prematurity by phototherapy. Pediatrics. 1968;41(6):1047–1054.
   PubMed Web of Science ®Google Scholar
• Newman TB, Klebanoff MA. Neonatal hyperbilirubinemia and long-term outcome: another look at the collaborative perinatal project. Pediatrics. 1993;92(5):651–657.
   PubMed Web of Science ®Google Scholar
• Arnold C, Tyson JE, Pedroza C, et al. Cycled phototherapy dose-finding study for extremely low-birth-weight infants: a randomized clinical trial. JAMA Pediatr. 2020;174(7):649–656.
   PubMed Web of Science ®Google Scholar
• Hansen TWR, Jeffrey Maisels M, Ebbesen F, et al. Sixty years of phototherapy for neonatal jaundice: from serendipitous observation to standardized treatment and rescue for millions. J Perinatol. 2020;40(10):1582–1583.
   PubMed Web of Science ®Google Scholar
• Newman TB, Kuzniewicz MW, Liljestrand P, et al. Numbers needed to treat with phototherapy according to American Academy of Pediatrics Guidelines. Pediatrics. 2009;123(5):1352–1359.
   PubMed Web of Science ®Google Scholar
• Jasprova J, Dal Ben M, Hurny D, et al. Neuro-inflammatory effects of photodegradative products of bilirubin. Sci Rep. 2018;8(1):7444.
   PubMedGoogle Scholar
• Bhutani VK, Johnson LH, Schwoebel A, et al. A systems approach for neonatal hyperbilirubinemia in term and near-term newborns. J Obstet Gynecol Neonatal Nurs. 2006;35(4):444–455.
   PubMed Web of Science ®Google Scholar
• Hammerman C, Goldstein R, Kaplan M, et al. Bilirubin in the premature: toxic waste or natural defense? Clin Chem. 1998;44(12):2551–2553.
   PubMed Web of Science ®Google Scholar
• Morris BH, Oh W, Tyson JE, et al. Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N Engl J Med. 2008;359(18):1885–1896.
   PubMed Web of Science ®Google Scholar
• Watchko JF, Maisels MJ. The enigma of low bilirubin kernicterus in premature infants: why does it still occur, and is it preventable? Semin Perinatol. 2014;38(7):397–406.
   PubMed Web of Science ®Google Scholar
• Wusthoff CJ, Loe IM. Impact of bilirubin-induced neurologic dysfunction on neurodevelopmental outcomes. Semin Fetal Neonatal Med. 2015;20(1):52–57.
   PubMed Web of Science ®Google Scholar
• Cashore WJ, Oh W. Unbound bilirubin and kernicterus in low-birth-weight infants. Pediatrics. 1982;69(4):481–485.
   PubMed Web of Science ®Google Scholar
• Funato M, Tamai H, Shimada S, et al. Vigintiphobia, unbound bilirubin, and auditory brainstem responses. Pediatrics. 1994;93(1):50–53.
   PubMed Web of Science ®Google Scholar
• Ahlfors CE, Wennberg RP, Ostrow JD, et al. Unbound (free) bilirubin: improving the paradigm for evaluating neonatal jaundice. Clin Chem. 2009;55(7):1288–1299.
   PubMed Web of Science ®Google Scholar
• Bratlid D. How bilirubin gets into the brain. Clin Perinatol. 1990;17(2):449–465.
   PubMed Web of Science ®Google Scholar
• Burgess GH, Oh W, Bratlid D, et al. The effects of brain blood flow on brain bilirubin deposition in newborn piglets. Pediatr Res. 1985;19(7):691–696.
   PubMed Web of Science ®Google Scholar
• Ahlfors CE. Bilirubin–albumin binding and free bilirubin. J Perinatol. 2001;21(Suppl. 1):S40–S42, discussion S59–S62.
   PubMedGoogle Scholar
• Palmela I, Sasaki H, Cardoso FL, et al. Time-dependent dual effects of high levels of unconjugated bilirubin on the human blood–brain barrier lining. Front Cell Neurosci. 2012;6:22.
   PubMed Web of Science ®Google Scholar
• Schinkel AP. Glycoprotein, a gatekeeper in the blood–brain barrier. Adv Drug Deliv Rev. 1999;36(2–3):179–194.
   PubMed Web of Science ®Google Scholar
• Hulzebos CV, Dijk PH. Bilirubin–albumin binding, bilirubin/albumin ratios, and free bilirubin levels: where do we stand? Semin Perinatol. 2014;38(7):412–421.
   PubMed Web of Science ®Google Scholar
• Ahlfors CE, Amin SB, Parker AE. Unbound bilirubin predicts abnormal automated auditory brainstem response in a diverse newborn population. J Perinatol. 2009;29(4):305–309.
   PubMed Web of Science ®Google Scholar
• Amin SB, Saluja S, Saili A, et al. Chronic auditory toxicity in late preterm and term infants with significant hyperbilirubinemia. Pediatrics. 2017;140(4):e20164009.
   PubMed Web of Science ®Google Scholar
• Hegyi T, Chefitz D, Weller A, et al. Unbound bilirubin measurements in term and late-preterm infants. J Matern Fetal Neonatal Med. 2020;1–7.
   Google Scholar
• Hansen TWR, Maisels MJ, Ebbesen F, et al. Sixty years of phototherapy for neonatal jaundice – from serendipitous observation to standardized treatment and rescue for millions. J Perinatol. 2020;40(2):180–193.
   PubMed Web of Science ®Google Scholar
• Hegyi T, Kathiravan S, Stahl GE, et al. Unbound free fatty acids from preterm infants treated with intralipid decouples unbound from total bilirubin potentially making phototherapy ineffective. Neonatology. 2013;104(3):184–187.
   PubMed Web of Science ®Google Scholar
• Hegyi T, Kleinfeld A, Huber A, et al. Unbound bilirubin levels in phototherapy-treated preterm infants receiving soy-based lipid emulsion. Pediatr Int. 2020;62(12):1357–1363.
   PubMed Web of Science ®Google Scholar
• Ruben S, Kleinfeld AM, Richeiri GV, et al. Serum levels of unbound free fatty acids. II: the effect of intralipid administration in premature infants. J Am Coll Nutr. 1997;16(1):85–87.
   PubMed Web of Science ®Google Scholar
• Wennberg RP. Measuring free bilirubin: the clinical perspective. Clin Chem. 2012;58(5):811–813.
   PubMed Web of Science ®Google Scholar
• Huber AH, Zhu B, Kwan T, et al. Fluorescence sensor for the quantification of unbound bilirubin concentrations. Clin Chem. 2012;58(5):869–876.
   PubMed Web of Science ®Google Scholar
• Iwatani S, Yamana K, Nakamura H, et al. A novel method for measuring serum unbound bilirubin levels using glucose oxidase-peroxidase and bilirubin-inducible fluorescent protein (UnaG): no influence of direct bilirubin. Int J Mol Sci. 2020;21(18):6778.
   PubMed Web of Science ®Google Scholar
• Amin SB, Saluja S, Saili A, et al. Auditory toxicity in late preterm and term neonates with severe jaundice. Dev Med Child Neurol. 2017;59(3):297–303.
   PubMed Web of Science ®Google Scholar
• Morioka I. Hyperbilirubinemia in preterm infants in Japan: new treatment criteria. Pediatr Int. 2018;60(8):684–690.
   PubMed Web of Science ®Google Scholar
• van der Schoor LW, Dijk PH, Verkade HJ, et al. Unconjugated free bilirubin in preterm infants. Early Hum Dev. 2017;106–107:25–32.
   PubMed Web of Science ®Google Scholar
• Newman TB, Escobar GJ, Gonzales VM, et al. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics. 1999;104(Suppl. 6):1198–1203.
   PubMedGoogle Scholar
• Newman TB, Maisels MJ. Less aggressive treatment of neonatal jaundice and reports of kernicterus: lessons about practice guidelines. Pediatrics. 2000;105(1 Pt 3):242–245.
   PubMed Web of Science ®Google Scholar